Business Trip artwork

MAPS PBC, rethinking the pharma business model and MDMA-assisted therapy

Business Trip

English - November 24, 2021 06:00 - 51 minutes - 35.6 MB
Entrepreneurship Business Health & Fitness Mental Health psychedelics psychedelic psychedelic startups mental health wellness human flourishing Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: On transformational ketamine therapy and running an integrative psychedelic clinic
Next Episode: PsyMed Ventures, our $25M fund to invest in psychedelic medicine & mental health tech

Today’s episode features Amy Emerson, the CEO of MAPS Public Benefit Corporation (PBC), which is a fully owned subsidiary of MAPS, and its purpose is to commercialize MDMA-assisted therapy. We discuss the MAPS PBC and it’s business model for MDMA-assisted therapy.

In this episode, we discuss:

MAPS’ protocol and strategy behind FDA clinical trial for PTSDAmy’s views on the state of the industry, patents, and how to prioritize accessibilityThe unique business model between MAPS and MAPS PBCPsychedelics for kids



Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin and Matias Serebrinsky
Produced by Jonathan A. Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh


Find us at businesstrip.fm
Follow us on Instagram and Twitter!


Theme music by Dorian Love
Additional music: Focus Does the Girl by Muted Circus

Twitter Mentions